ERBB2 and breast carcinoma: Breast cancer with the genetic signature of ER-negative, PR-negative, and ERBB2/HER2-negative has been classified as triple-negative breast cancer (TNBC) [8], which represents the most aggressive clinical subtype with a poor prognosis.